What is the significance of an Anti-DNA, Double Stranded (Anti-DS DNA) result of 5?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Significance of Anti-DNA, Double Stranded Result of 5

An Anti-DNA, Double Stranded (Anti-dsDNA) result of 5 is likely within the normal reference range and does not indicate systemic lupus erythematosus (SLE) or active disease. This value should be interpreted in the context of the specific laboratory method used, clinical symptoms, and other autoantibody results.

Understanding Anti-dsDNA Testing

Anti-dsDNA antibodies are highly specific markers for SLE diagnosis and disease activity monitoring. However, interpretation depends on several factors:

Laboratory Methods and Reference Ranges

  • Different testing methods have varying sensitivities and specificities:

    • ELISA: ~90% specificity
    • ELiA: 95.9% specificity
    • CLIFT (Crithidia luciliae immunofluorescence test): 96-97% specificity 1
  • A result of 5 is typically below the positive threshold for most assays, though this depends on the specific laboratory's reference range and testing method

Clinical Significance of Anti-dsDNA

Diagnostic Value

  • Anti-dsDNA antibodies are one of the immunological criteria in the EULAR/ACR 2019 classification for SLE 2
  • These antibodies are highly specific for SLE but can occasionally be found in:
    • Healthy individuals (usually low-affinity IgM type) 3
    • Other autoimmune conditions
    • Certain infections
    • Cancer 2

Disease Activity Monitoring

  • Rising anti-dsDNA levels often correlate with disease activity and can predict disease flares 8-10 weeks before clinical manifestation 4
  • Anti-dsDNA antibodies are particularly associated with lupus nephritis 2

Recommended Next Steps

For Patients Without Known SLE

  1. Check ANA status first:

    • If ANA is negative, SLE is unlikely (anti-dsDNA testing is not recommended with negative ANA except with high clinical suspicion) 2
    • If ANA is positive with clinical symptoms suggestive of SLE, further autoantibody testing is warranted
  2. Consider confirmatory testing:

    • If clinical suspicion remains high despite negative/low anti-dsDNA:
      • Repeat testing in 3-6 months 2
      • Consider using a different testing method (CLIFT is more specific) 2
      • Test for other autoantibodies (anti-Sm, anti-Ro/SSA, anti-La/SSB)

For Patients With Known SLE

  • A low anti-dsDNA value suggests inactive disease or good disease control
  • Continue monitoring every 6-12 months if disease is inactive 2, 1
  • More frequent monitoring is needed for active disease 1

Important Considerations

Testing Strategy

  • The most efficient strategy for anti-dsDNA detection combines:
    • ANA pattern assessment (homogeneous or speckled patterns are most associated with SLE)
    • Two quantitative methods (e.g., RIA+CLIA) for confirmation 5

Common Pitfalls

  • Relying solely on anti-dsDNA without clinical correlation may lead to misdiagnosis
  • Anti-dsDNA levels should be interpreted alongside other disease markers:
    • Complement levels (C3, C4) - often inversely correlated with disease activity 2, 1
    • Complete blood count - to detect cytopenias 1
    • Renal function tests - for lupus nephritis 1

Key Takeaway

A single anti-dsDNA value of 5 is likely normal and not indicative of SLE or active disease. However, if clinical symptoms suggest SLE, comprehensive autoantibody testing and clinical evaluation are necessary for accurate diagnosis and management.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.